Mindray to Acquire a Controlling Stake in Optcla
Under the agreement, Optcla will give Mindray access to its rigid endoscope and related surgical devices as well as its R&D, manufacture, sales and services capabilities. This acquisition will further supplement and extend Mindray’s existing total solutions for hospital operation rooms, cater to the market trend of increasing demand for minimally invasive operations and digitalized operations, as well as bringing new growth for Mindray.
Optcla will be operated independently under its former management team after the acquisition. Mindray has no plans to change Optcla’s employee base. Mindray will also honor all of Optcla’s contracts as agreed upon prior to the acquisition and maintain Optcla’s current policies on sale and after-sale service.
Mindray will use its strong platforms in sales, manufacture, R&D, quality assurance and human resources to support Optcla’s future development. Mindray aims to work diligently with Optcla to help the company become a leader in the promising rigid endoscope and related surgical devices business in China.
We believe the collaboration between Mindray and Optcla will bring many synergies to both parties. Together, we will provide better products and services to our customers, and broader development opportunities to our employees. Mindray will also help strengthen Optcla’s position in the marketplace.
Optcla is a leading high-tech enterprise headquartered in Tonglu, Hangzhou, China, mainly engaged in R&D, design, manufacturing and sale of rigid endoscope and related minimally invasive surgical devices. For more information, please refer to www.hzguangdian.com.cn.
May 09, 2012
Open WeChat and Scan the QR code .Get the Webpage and Share on Moments.
Mindray in Global Actions to Combat COVID-19: Mindray at CMEF 20202020-10-20
Mindray Brings Groundbreaking New Systems to the High-End Anesthesia System Market2020-10-15
BC-7500 CRP, Empowering Pediatric Care2020-08-31
Mindray Sets A New Standard for Infusion Pump with the BeneFusion n Series Infusion System2020-08-18
Mindray's most Invested R&D Center Announced Construction2020-06-20